FDA Approves First Drug for Moderate and Severe Eczema CasesHighlights
- Dupixent is an antibody that is injected just under the skin.
- Injection will have initial list price of USD 37000 per year, as per sanofi SA and Regeneron Pharmaceuticals.
- In two large tests of the drug, one-third to two-thirds of patients achieved clear or nearly clear skin.
- Eczema treatments have generally been limited to topical medications
- Steroid creams
- Moisturizers
- Ultraviolet light
- Dupixents active ingredient is an antibody that binds to a protein that causes inflammation.
About FDA
- Is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
- Is responsible for protecting and promoting public health through the control and supervision of food safety.
- Is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate.
- Its headquarters in unincorporated White Oak, Maryland.
Regulatory programs:
✍Examrace Team at Aug 21, 2021